May 2018

Parkinson’s disease + anxiety/depression: Stigma-busting for Mental Health Month

Stress. Anxiety. Depression. Have you experienced any of these along with Parkinson’s disease (PD)? As National Mental Health Month comes to a close, we’re highlighting how common these non-motor symptoms and mental health issues are among people with PD. Plus, see some new research on the prevalence of feeling demoralized (vs. depressed) with PD, and […]

Parkinson’s disease + anxiety/depression: Stigma-busting for Mental Health Month Read More »

Cannabidiol (CBD) oil and product FAQs: Fad or effective? Legal or not?

Trending: Cannabidiol (CBD) oil, gummies, tinctures and more. Why are cannabis products gaining popularity as medical treatments and in general? As more states have legalized medical marijuana, more people have shifted their views on cannabis treatments (like former Speaker of the House John Boehner’s recent change of heart). And last month, an advisory panel at the U.S. Food and

Cannabidiol (CBD) oil and product FAQs: Fad or effective? Legal or not? Read More »

Lights out: Bedtime tips to help you sleep through the night

Do you have a bedtime routine? Sleep is a challenge for many members in the mental health community — over 3,000 PatientsLikeMe members say they have difficulty sleeping through the night. Establishing a regular bedtime and better sleep hygiene is one way to help manage restless nights. Check out some pointers from around the web, and hear

Lights out: Bedtime tips to help you sleep through the night Read More »

Probiotics for MS? The latest research

Wondering if a probiotic could help treat your MS? With 10 forum threads on the topic, you’re not the only one. From conflicting information online to recommendations from friends and new research making headlines, separating fact from fiction can be tricky. Here’s a recap of the latest research on probiotics and MS from our in-house team of health professionals.

Probiotics for MS? The latest research Read More »

Can ketamine help when antidepressants don’t? A closer look at the off-label drug that’s in the spotlight

You may have seen ketamine making headlines recently as a promising drug therapy for treatment-resistant depression, or “TRD.” (What’s TRD? Health care professionals define it as receiving at least two different antidepressants– for at least six weeks in a row, and at an adequate dosage – but experiencing less than a 50% improvement in depressive symptoms.) So,

Can ketamine help when antidepressants don’t? A closer look at the off-label drug that’s in the spotlight Read More »

What’s in your “chemo bag”? Gearing up for lung cancer treatment

Chemotherapy is one of the most common treatments for lung cancer, so the community on PatientsLikeMe is chatting about what’s helpful to pack in a bag for chemo appointments (join PatientsLikeMe to take part in this lung cancer forum discussion). Everyone’s experiences, side effects and preferences are different, but here are some items that people who’ve had chemotherapy say

What’s in your “chemo bag”? Gearing up for lung cancer treatment Read More »

Spill the beans: How do caffeine and Parkinson’s disease interact?

Do you crave that cup (or more) of joe each day? Or a spot of tea or chunk of chocolate? Research about caffeine and Parkinson’s disease (PD) has been all over the map. What have studies shown? And what’s the PatientsLikeMe community’s take on caffeine and its effects when you’re living with PD? Take a

Spill the beans: How do caffeine and Parkinson’s disease interact? Read More »

Member Christine’s Instagram takeover for World Lupus Day

In case you missed it or you’re not on Instagram, on World Lupus Day (May 10), PatientsLikeMe member Christine took over our Instagram to share her experiences and help raise awareness of lupus (May is Lupus Awareness Month). Christine is a native Californian, a social butterfly, an advocate and a member of our 2018 Team of Advisors (check

Member Christine’s Instagram takeover for World Lupus Day Read More »

2 immunotherapy treatments in the news: Imfinzi and Keytruda update

Two immunotherapy treatments — Imfinzi (durvalumab) and Keytruda (pembrolizumab) — have made headlines recently in relation to lung cancer treatment. What’s the latest? Here’s an update. Expanded FDA approval for Imfinzi The U.S. Food and Drug Administration (FDA) first approved Imfinzi as a bladder cancer treatment in 2017. Imfinzi is marketed by AstraZeneca. In February 2018, the FDA approved

2 immunotherapy treatments in the news: Imfinzi and Keytruda update Read More »

Health news: What’s making headlines this month

Let’s stay on top of the latest health news — in case you missed it, check out this round up of some of the stories making headlines in May. ALS May is ALS awareness month: Later this month, advocates from across the U.S. will head to Capitol Hill to meet with their legislators. Check out how

Health news: What’s making headlines this month Read More »

Scroll to Top